A sweeping change to federal hemp law is approaching, and a new economic analysis suggests the consequences could reach far beyond THC gummies and intoxicating hemp drinks. The forthcoming restrictions could remove most hemp-derived cannabinoid products from the federally legal hemp market, erase tens of billions of dollars in retail activity and displace more than 225,000 American workers. The impact could extend from farmers and extraction companies to beverage manufacturers, CBD brands, distributors and thousands of independent retailers that have built businesses around the hemp industry created by the 2018 Farm Bill.
The warning comes from Whitney Economics, which surveyed hemp businesses across 35 states for its 2026 U.S. Hemp Cannabinoid Report. The firm estimates the hemp-derived cannabinoid sector now represents a $38.7 billion total addressable market and supports roughly 350,000 jobs paying $13.9 billion in wages. If the new federal definition of hemp takes effect substantially as written, however, the researchers estimate retail revenues could decline by $28.3 billion, as many as 225,861 jobs could disappear and approximately $8.9 billion in worker wages could be lost. Perhaps most strikingly, businesses surveyed for the report estimated that only about 8.5 percent of current cannabinoid products would remain available under the new federal framework.
How the 2018 Farm Bill Created the Modern Hemp Market
The modern hemp industry largely traces its growth to the Agriculture Improvement Act of 2018. That law removed hemp from the federal definition of marijuana when Cannabis sativa plants and their derivatives contained no more than 0.3 percent delta-9 THC on a dry-weight basis. The change was designed primarily to restore industrial hemp as an agricultural crop, but the wording also created a legal pathway for an enormous range of cannabinoid products. CBD became the first major consumer market, followed by delta-8 THC, hemp-derived delta-9 edibles and beverages, high-THCA flower and other products produced from federally lawful hemp.
The distinction between delta-9 THC concentration and the total amount of THC inside a finished product became particularly important. Manufacturers could produce gummies, drinks and other products containing enough hemp-derived THC to create intoxicating effects while remaining within the 0.3 percent delta-9 THC dry-weight standard. THCA flower presented another issue because THCA converts into intoxicating delta-9 THC when heated. Meanwhile, chemical conversion processes made it possible to produce cannabinoids such as delta-8 THC from hemp-derived CBD. Federal lawmakers, state regulators and public-health officials increasingly argued that the original hemp definition was allowing psychoactive products to be sold outside the more heavily regulated state marijuana systems.
The New Federal Definition Changes the Rules
Congress altered that system through Section 781 of the fiscal year 2026 agriculture appropriations legislation enacted in November 2025. The new definition moves away from relying primarily on delta-9 THC and instead incorporates total THC, including THCA. It also creates separate restrictions for intermediate cannabinoid materials and finished consumer products, while excluding certain cannabinoids that are synthesized or manufactured outside the cannabis plant.
For finished hemp-derived cannabinoid products, the most consequential provision establishes a maximum of 0.4 milligrams per container of combined total tetrahydrocannabinols and other cannabinoids determined to have effects similar to THC. That is a dramatically different standard from the percentage-based rule established in 2018. A consumer package containing multiple gummies, a bottle of tincture or a multipack of beverages could exceed 0.4 milligrams even when THC represents only a tiny portion of the product’s overall weight. Products that fall outside the revised federal hemp definition would no longer receive the federal legal treatment granted to hemp and could instead fall within federal controlled-substance law governing marijuana.
The Restrictions Could Reach Far Beyond Intoxicating THC Products
Much of the debate has focused on delta-8 gummies, hemp-derived THC drinks and high-THCA flower, but the economic report suggests the effect could be much broader. Full-spectrum CBD products commonly contain naturally occurring trace amounts of THC because they retain multiple compounds found in the hemp plant. A bottle containing dozens of servings can therefore contain more than 0.4 milligrams of THC across the entire container even though no individual dose produces an intoxicating effect. Industry representatives have argued that this could remove established CBD oils, capsules, gummies and other wellness products along with products specifically designed to produce a high.
Whitney Economics attempted to quantify that exposure by asking hemp operators how their existing product portfolios would fare under the restrictions. According to the report, respondents estimated that only 8.5 percent of cannabinoid products would remain available if the federal provisions take full effect without substantial modification. That does not represent a federal government count of prohibited products, and the exact number of individual products affected will depend on formulations and regulatory implementation. Nevertheless, it suggests that thousands of existing products across the national hemp marketplace could require reformulation, removal or movement into another regulatory system.
More Than 225,000 Jobs Could Be Displaced
The employment numbers illustrate why the approaching deadline has become an economic issue as well as a cannabis policy debate. Whitney Economics estimates approximately 350,000 people currently work within the hemp-derived cannabinoid sector, collectively earning about $13.9 billion in wages. Those jobs are spread across farming, extraction, manufacturing, testing, packaging, logistics, wholesale distribution, retail, marketing and numerous supporting industries. Hemp-derived products have also become important revenue sources for convenience stores, specialty shops, breweries and beverage companies in states where hemp cannabinoids have developed into mainstream consumer goods.
The report projects employment could decline by as many as 225,861 workers, with lost wages reaching approximately $8.9 billion. Survey responses offer some insight into how that contraction might occur: 68.1 percent of participating businesses said they expected to close under the federal restrictions as written, while another 15.5 percent anticipated laying off workers. Smaller percentages expected to remain open with reduced revenue or relocate operations. Whitney Economics estimates the broader economic effect across hemp-related sectors could reach $86.6 billion in lost economic output if the modeled impacts occur in full. These figures are projections based on industry survey data rather than observed job losses, but they demonstrate the scale of disruption operators say they are preparing for.
States Could Lose Billions in Economic Activity and Tax Revenue
The hemp cannabinoid market does not operate exclusively through cannabis dispensaries. In many states, products are sold through liquor stores, supermarkets, convenience stores, wellness retailers, smoke shops, restaurants and online businesses. THC beverages in particular have become a significant new category in some markets, with breweries and beverage companies using hemp-derived cannabinoids to diversify as traditional alcohol consumption patterns change. The federal restrictions could therefore affect businesses that would not ordinarily consider themselves part of the marijuana industry.
Whitney Economics estimates states could lose approximately $2.1 billion in potential sales-tax revenue under its modeled scenario. The research firm also estimates that the majority of roughly 50,000 hemp operators nationwide could disappear from the domestic market. Because state rules already vary dramatically, however, the consequences will not be identical everywhere. Some states have already banned or severely restricted intoxicating hemp cannabinoids, while others have developed licensing systems, age limits, laboratory-testing standards, packaging rules and THC serving limits intended to keep products legal while placing them under greater oversight.
Supporters Say the Existing Hemp Market Has Major Regulatory Problems
The push to change federal hemp law did not develop solely from opposition to the industry’s economic growth. State cannabis regulators and other supporters of tighter restrictions have argued that the 2018 definition created loopholes that permitted intoxicating products to enter commerce without the safeguards required in many licensed marijuana markets. Regulators have highlighted the delta-9 percentage standard, the treatment of THCA and the conversion of hemp compounds into other intoxicating cannabinoids as areas where federal law failed to anticipate the consumer market that followed legalization.
Concerns have included products being sold without consistent potency testing, child-resistant packaging or universal age requirements, as well as intoxicating gummies and drinks appearing in convenience stores and other locations accessible to younger consumers. Licensed marijuana businesses have also argued that hemp-derived THC companies can compete with them without carrying the same licensing costs, taxes and regulatory burdens. Supporters of the federal changes therefore describe the measure as closing unintended gaps in the 2018 Farm Bill rather than banning traditional industrial hemp. The dispute increasingly centers on whether those problems require a near-zero national THC threshold or could instead be addressed through age restrictions, testing, labeling, dosage limits and state-level regulation.
The Federal Deadline Has Already Shifted Once
The timeline has become more complicated after Congress intervened again in September 2026. Section 781 was originally scheduled to take effect 365 days after the November 12, 2025 enactment of Public Law 119-37. Congress subsequently passed Public Law 119-103, which limits the application of most of the new hemp provisions until December 11, 2026. Congressional Research Service analysis now describes portions of the new federal definition as delayed until that December date.
There is an important exception. Products containing cannabinoids that are not capable of being naturally produced by Cannabis sativa remain within provisions scheduled to begin applying November 12. For much of the existing market involving naturally occurring cannabinoids, including the 0.4-milligram finished-product threshold, December 11 has become the central date businesses are watching. The short extension gives companies additional time to plan, but it does not remove the underlying statutory changes. Some operators are already reducing inventory, slowing production or developing product lines that do not depend on hemp cannabinoids because manufacturing and supply-chain decisions must often be made months in advance.
Lawmakers Are Considering an Alternative State-Regulation Approach
One attempt to prevent the federal restrictions from dismantling state-regulated markets is the Hemp Safety Enforcement Act, introduced in the Senate in April 2026 by Sen. Rand Paul of Kentucky with bipartisan support from Sen. Amy Klobuchar of Minnesota and, at introduction, Sen. Joni Ernst of Iowa. The proposal would allow qualifying states and Tribal governments to assume greater control over hemp regulation while maintaining safety requirements, including minimum-age restrictions and limits involving certain synthetic cannabinoids. It also addresses interstate commerce between jurisdictions participating in the alternative system.
As of October 3, the bill has not advanced beyond referral to the Senate Committee on Agriculture, Nutrition and Forestry. That leaves hemp businesses operating under substantial uncertainty only weeks before the federal changes begin affecting different categories of products. Industry advocates have pushed for regulations based on age restrictions, standardized testing, labeling and reasonable THC limits rather than the 0.4-milligram-per-container threshold. Supporters of the existing federal law continue to emphasize youth access, inconsistent regulation and the rapid spread of intoxicating products outside traditional marijuana systems. Congress therefore faces competing proposals over whether hemp-derived cannabinoids should remain a broad federally lawful product category, be governed primarily by states or largely move into controlled-substance and regulated cannabis frameworks.
A Defining Moment for the American Hemp Industry
Seven years after the 2018 Farm Bill launched an unprecedented expansion of the American hemp market, the industry is approaching what could be its most significant regulatory reset. What began largely as an agricultural effort built around fiber, grain and CBD evolved into a national cannabinoid marketplace containing THC beverages, edibles, smokable flower, extracts and thousands of formulations sold well beyond licensed cannabis dispensaries. Federal lawmakers are now attempting to draw a much narrower boundary around what can legally remain hemp.
The economic stakes are substantial. Whitney Economics projects $28.3 billion in potential lost retail revenue, more than 225,000 displaced jobs, $8.9 billion in lost wages and only a small fraction of existing cannabinoid products surviving the new rules unchanged. Those numbers represent modeled outcomes rather than guaranteed losses, and Congress could still alter the framework before all provisions take effect. What is already clear is that the coming federal definition will affect far more than a handful of controversial intoxicating cannabinoids. Unless lawmakers adopt another approach, the change could reshape the entire U.S. hemp-derived cannabinoid market, including businesses and products that have operated openly under federal hemp law since the passage of the 2018 Farm Bill.
